Teva Should Be Forced Back Into N.Y. Opioid Case, State Says (2)

Teva Pharmaceutical Industries Ltd. should return to court to explain “significant and intentional misrepresentations” it made in winning dismissal from a high-stakes opioid case last year, New York’s attorney general said.

The Israeli company misled a judge about the extent of its US transactions to avoid a trial in which its US unit was ultimately found liable for creating a “public nuisance” with its opioid marketing, New York Attorney General Letitia James said in a court filing Monday.

A finding against the parent company could impact whether the US unit can afford to pay damages that will be determined by ...